GLP-1 Agonists for Obesity—A New Recipe for Success?

This Viewpoint discusses the drawbacks of using glucagon-like peptide 1 (GLP-1) agonists to treat obesity and presents an alternative approach of initial, stage

Related Keywords

Boston , Massachusetts , United States , Tufts University , Dariush Mozaffarian , Eli Lilly , Acasti Pharma , Gates Foundation , Diabetes Prevention Program , National Institutes Of Health , Instacart Health , National Association Of Chain Drug Stores Foundation , Validation Institute , Elysium Health , Kaiser Permanente Fund , Google , Season Health , Rockefeller Foundation , Friedman School Of Nutrition Science , Novo Nordisk , Food Is Medicine , Obesity Treatment , Friedman School , Nutrition Science , Interest Disclosures , National Institutes , National Association , Chain Drug Stores Foundation , Beren Therapeutics , January Inc , Perfect Day , Tiny Organics ,